Newly Published Research Connects ME/CFS and Covid-19

Unique collaboration between Harvard, Johns Hopkins and citizen-scientist supported by Solve M.E. A comprehensive review of ME/CFS and Long Covid research published this week suggests that symptoms of both may be caused by redox imbalance, which is linked to inflammation and reduction of cellular energy production. [Redox imbalance occurs when oxidants and antioxidants in a […]

Read More

We’re Taking the CDC’s Draft Review of ME/CFS Diagnosis and Treatment to Congress

In 2018, the Centers for Disease Control (CDC) announced it was soliciting bids to create evidence-based treatment guidelines for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In 2019, the CDC announced a contract with the Pacific Northwest Evidence-Based Practice Center (EPC). The draft of this work, a Draft Systematic Evidence Review, was shared with the public for the […]

Read More

Harnessing the Power of Big Data to Understand Long Covid

By Sadie Whittaker, Chief Scientific Officer, Solve M.E. Many Covid-19 patients experience debilitating symptoms for months after the acute phase of the disease. Researchers worldwide have been collecting much-needed patient data on Long Covid. We are among them–we opened our patient registry, called You + ME, to those with Long COVID in December. Our enrollment […]

Read More

Solve M.E. Advocacy Changing the Face and Funding of Clinical Trials

Lowering the costs and barriers for participation in clinical trials is a key priority for Solve M.E.  For the past three years, Solve M.E. has endorsed and advocated for the passage of H.R. 913, The Clinical Treatment Act. Initially introduced in 2019 by Representatives Ben Ray Lujan (D-NM-03) and Gus Bilirakis (R-FL-12), this new law guarantees coverage […]

Read More

The Path to Diagnostics for ME/CFS: Can Long Covid Pave a Short-Cut?

By Oved Amitay, President and CEO, Solve M.E. It is often said that there are no biomarkers for ME/CFS. In fact, a number of objective measurable biological differences between people with ME/CFS and healthy individuals have been observed over the years. Yet we are missing diagnostic biomarkers that can be readily used to make a […]

Read More

Long COVID Alliance in TIME and The New York Times

In response to COVID-19, Solve M.E. co-founded the Long COVID Alliance (LCA), a network of patient-advocates, scientists, disease experts, and drug developers who have joined together to leverage collective knowledge and resources to educate policy makers and accelerate research to transform our understanding of post-viral illness. Since the LCA’s launch in early 2021, we continue […]

Read More

Solve M.E. CEO Oved Amitay Joins World Health Organization Seminar on Long COVID

On Tuesday, June 15, Solve M.E. President and CEO Oved Amitay joined other experts as a participant in the second seminar in a series presented by the World Health Organization (WHO) designed to improve our understanding of the Post COVID-19 condition and optimize the health of patients who have suffered from COVID-19.   In the first […]

Read More

Solve M.E., Long COVID Alliance highlighted in U.S. News & World Report

In her U.S. News & World Report article, “In Long COVID, Advocates Battling Chronic Fatigue Syndrome See Allies, Hope,” journalist Chelsea Cirruzzo examines the ME/CFS and Long COVID connection, and how the striking similarities are fueling hopes that research can uncover solutions for both. Mentioned in the piece are Solve M.E. President Oved Amitay and the Long COVID […]

Read More

Solve M.E. President Oved Amitay Featured on PBS’ White House Chronicle

Fresh off a recent appearance on Llewellyn King’s ME/CFS Alert, Solve M.E. President and CEO Oved Amitay will be the featured guest on King’s PBS show White House Chronicle, premiering today, April 9. In the episode, King and Amitay discuss Solve M.E.’s efforts to improve education, diagnostics and funding for ME/CFS, how to create a more equitable […]

Read More